These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36660284)

  • 1. Supply chain concentration and corporate financialization.
    Zou M; Zhang X
    Front Psychol; 2022; 13():934753. PubMed ID: 36660284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
    Zhao XZ; Chen J; Chen FW; Wang W; Xia S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supply Chain Power and Corporate Environmental Responsibility: Mediation Effects Based on Business Performance.
    Luo T; Xie R
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do local governments' energy-saving target constraints inhibit financialization? Evidence from nonfinancial listed firms in China.
    Hu G; Yu Y; Wang Q
    PLoS One; 2023; 18(5):e0285342. PubMed ID: 37205686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supply chain concentration and enterprise financialization: Evidence from listed companies in China's manufacturing industry.
    He H; Zuo Z
    PLoS One; 2023; 18(5):e0285308. PubMed ID: 37163518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does green finance restrain corporate financialization?
    Zhou C; Qi S
    Environ Sci Pollut Res Int; 2023 Jun; 30(27):70661-70670. PubMed ID: 37155100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supply network position, digital transformation and innovation performance: Evidence from listed Chinese manufacturing firms.
    Du C; Zhang Q
    PLoS One; 2022; 17(12):e0279133. PubMed ID: 36520812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does digital finance improve the green investment of Chinese listed heavily polluting companies? The perspective of corporate financialization.
    Jiang Y; Guo C; Wu Y
    Environ Sci Pollut Res Int; 2022 Oct; 29(47):71047-71063. PubMed ID: 35595899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the new Environmental Protection Law on corporate financialization in China.
    Xie G; Yang Y; Jiang K; Chen Z
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):83596-83611. PubMed ID: 35764736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Political turnover and corporate financialization: Evidence from China.
    Lyu S; Qi Y; Yang S; Dong S
    Front Psychol; 2022; 13():1039560. PubMed ID: 36389499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do carbon emissions trading impact the financialization of non-financial companies? Evidence from a quasi-natural experiment in China.
    Ma W; Yan X
    PLoS One; 2023; 18(12):e0296277. PubMed ID: 38150448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of corporate financialization and labor cost growth: Evidence from China's new asset management rules.
    Liu C
    PLoS One; 2023; 18(6):e0286683. PubMed ID: 37267280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital transformation and corporate financialization in emerging markets: Evidence from China.
    Fang X; Ju C
    Heliyon; 2024 Jan; 10(2):e24616. PubMed ID: 38298705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling manufacturing firms' supply chain performance in the Middle East region through boosting the quality of multi-directional relationship, and supply chain risk dilution: A moderated-mediation model.
    Anwer Al-Shboul M
    Heliyon; 2023 Nov; 9(11):e22059. PubMed ID: 38034646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental uncertainty and digital technologies corporate in shaping corporate green behavior and tax avoidance.
    Ao XY; Ong TS; Aprile R; Di Vaio A
    Sci Rep; 2023 Dec; 13(1):22170. PubMed ID: 38092819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of subscribing to directors' and officers' liability insurance on corporate financialization: Evidence from China.
    Peng C; Fu W; Zhang X; Jiang H
    Front Psychol; 2022; 13():986135. PubMed ID: 36186362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a moderate range of impact of financialization on corporate R&D?
    Li Z; Wang Y
    PLoS One; 2021; 16(6):e0253380. PubMed ID: 34191824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of digital technology application and supply chain management on corporate circular economy: A dynamic capability view.
    Yuan S; Pan X
    J Environ Manage; 2023 Sep; 341():118082. PubMed ID: 37141715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.